These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. A Mycobacterium ulcerans vaccine pilot trial using an accurate low-dose challenge. Muhi S, Porter JL, Stinear TP. Microbiol Spectr; 2024 Aug 06; 12(8):e0055524. PubMed ID: 38916323 [Abstract] [Full Text] [Related]
8. Protective effect of a dewaxed whole-cell vaccine against Mycobacterium ulcerans infection in mice. Watanabe M, Nakamura H, Nabekura R, Shinoda N, Suzuki E, Saito H. Vaccine; 2015 May 05; 33(19):2232-2239. PubMed ID: 25825332 [Abstract] [Full Text] [Related]
10. Buruli ulcer. Einarsdottir T, Huygen K. Hum Vaccin; 2011 Nov 05; 7(11):1198-203. PubMed ID: 22048117 [Abstract] [Full Text] [Related]
11. In Vivo Imaging of Bioluminescent Mycobacterium ulcerans: A Tool to Refine the Murine Buruli Ulcer Tail Model. Omansen TF, Marcsisin RA, Chua BY, Zeng W, Jackson DC, Porter JL, Stienstra Y, van der Werf TS, Stinear TP. Am J Trop Med Hyg; 2019 Dec 05; 101(6):1312-1321. PubMed ID: 31595865 [Abstract] [Full Text] [Related]
12. Systematic review of M. Bovis BCG and other candidate vaccines for Buruli ulcer prophylaxis. Muhi S, Stinear TP. Vaccine; 2021 Dec 08; 39(50):7238-7252. PubMed ID: 34119347 [Abstract] [Full Text] [Related]
13. Structural basis and designing of peptide vaccine using PE-PGRS family protein of Mycobacterium ulcerans-An integrated vaccinomics approach. Nain Z, Karim MM, Sen MK, Adhikari UK. Mol Immunol; 2020 Apr 08; 120():146-163. PubMed ID: 32126449 [Abstract] [Full Text] [Related]
14. Interferon-γ Is a Crucial Activator of Early Host Immune Defense against Mycobacterium ulcerans Infection in Mice. Bieri R, Bolz M, Ruf MT, Pluschke G. PLoS Negl Trop Dis; 2016 Feb 08; 10(2):e0004450. PubMed ID: 26863011 [Abstract] [Full Text] [Related]
15. Protective efficacy of a DNA vaccine encoding antigen 85A from Mycobacterium bovis BCG against Buruli ulcer. Tanghe A, Content J, Van Vooren JP, Portaels F, Huygen K. Infect Immun; 2001 Sep 08; 69(9):5403-11. PubMed ID: 11500410 [Abstract] [Full Text] [Related]
16. Use of Recombinant Virus Replicon Particles for Vaccination against Mycobacterium ulcerans Disease. Bolz M, Kerber S, Zimmer G, Pluschke G. PLoS Negl Trop Dis; 2015 Sep 08; 9(8):e0004011. PubMed ID: 26275222 [Abstract] [Full Text] [Related]
17. Immunogenicity of Mycobacterium ulcerans Hsp65 and protective efficacy of a Mycobacterium leprae Hsp65-based DNA vaccine against Buruli ulcer. Coutanceau E, Legras P, Marsollier L, Reysset G, Cole ST, Demangel C. Microbes Infect; 2006 Jul 08; 8(8):2075-81. PubMed ID: 16781179 [Abstract] [Full Text] [Related]